Registration Study of Takayasu's Arteritis in China

NCT03199183 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1067

Last updated 2019-01-25

No results posted yet for this study

Summary

Takayasu arteritis(TA) is a chronic progressive vasculitis predominantly affecting the aorta and its major branches. The demographic, clinical and prognostic features of Takayasu arteritis in China remains in uncertainties. Investigators aim to setup a national registration study for Takayasu arteritis, to observe the prevalence, clinical manifestations, natural history, survival, progression, diagnostic and therapeutic methods of the disease in China.

Conditions

  • Takayasu Arteritis

Interventions

RADIATION

PET-CT

PET-CT will be proceed on the basis of clinical status and aspiration of individual patient. The imaging results will be analysed by professional radiologists.

OTHER

laboratory biomarker analysis

Screening of potential biomarkers related to Takayasu arteritis and verification tests will be operated.

GENETIC

genetic sequencing

Genetic sequencing results will be analysed to identify susceptible alleles or single nucleotide polymorphisms of Takayasu arteritis.

Sponsors & Collaborators

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Huimin Zhang, MD. · Chinese Academy of Medical Sciences, Fuwai Hospital

  • Jun Cai, MD.PhD. · Chinese Academy of Medical Sciences, Fuwai Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2020-07-01
Completion
2020-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03199183 on ClinicalTrials.gov